AREV Engages Dr. Jay Noller to Join the Advisory Board


VANCOUVER, BC – TheNewswire - February 19, 2021 - AREV NANOTEC BRANDS INC. (CSE:AREV) (CNSX:AREV.CN) (OTC:AREVF) (“AREV Brands”) is pleased to announce the appointment of Dr. Jay Noller to its Scientific Advisory Board.


Dr. Jay Noller, PhD, is a globally recognized polymath in agriculture, environmental and earth sciences, archaeology, and visual arts. He has led organizations that provided diverse activities in education, research, extension, and public service relevant to seed production, soils and ecosystem services, small farms and community food systems, integrated pest management, and various approaches to natural resource management. He has served in numerous roles as leader or administrator of several enterprises that provide wheat, potatoes and other food commodities to the world at large as well as to food systems at community level.

Prof. Noller is a Professor Emeritus and is the founding Director and lead researcher of Oregon State University’s (OSU) Global Hemp Innovation Center. The Center is the world’s most comprehensive research center devoted to the study of hemp providing the most comprehensive knowledge of hemp innovation to be found anywhere. The Center is advancing the research of hemp and its market potential across multiple diverse industries and research fields to serve the growing international demand for innovative approaches to food, health, and fiber. Prof. Noller has been Oregon’s leader in hemp research and policy since 2014 and has developed research partnerships with over 40 institutions globally devoted to improving hemp genetics and modes of production and processing for fiber, grain essential oils, and advances in new classes of hemp varieties. He has directed hemp research and related industrial projects across North America, China, and Europe.


Dr. Noller is Professor Emeritus, with career of research involving the disciplines of soil science, geomorphology, art, and archaeology. In addition to his hemp projects, his research principally focused on human interactions with soils in modern and ancient agricultural and forest landscapes of the Middle East, Europe and the Americas. His experience includes more than 50 large projects, spanning much of North and South America, southern Europe, southwest Asia, and Africa. He has published more than 200 papers and maps, six books and has made contributions to additional works. He is also an internationally known soil artist creating large eco‐artwork installations and fine‐art paintings on display and in collections around the world.


Mike Withrow CEO commented, “We are pleased to welcome Dr. Noller to the AREV Scientific Advisory Board.  His expertise in innovation and knowledge of human nutrition and methodology in phytomedicinal discovery will enhance our immediate corporate goals and allow significant contributions to the life science industry.”

“Feed the world better has been a long-held mantra of mine since I became a scholar in agriculture decades ago,” said Prof. Noller, “I look forward to providing an advisory role to AREV NanoTec in their quests to provide for a healthier humanity through better nutritional supports, such as RUTFs.”


The company has issued 100,000 stock options to Directors, Officers and Consultants of the Company at a price of $0.305 for a period of 5 years from the issued date. These options will vest immediately.


For further information, contact Mike Withrow, 778-929-6536. For more information visit

On behalf of the Board,

Mike Withrow
CEO & Director

About AREV NanoTec Inc.  
AREV NanoTec Brands Inc. (“AREV”) produces and sells functional ingredients produced via its proprietary extraction systems. These premium ingredients and products are targeted for the natural health, medical, functional food, nutraceutical, sport nutrition markets for both the human and pet market. AREV’s model is to toll process extraction of targeted essential and functional oils and license its formulations to Licensed Producers in Canada.  The company utilizes toll processors in foreign countries to encapsulate and package its formulations that can be sold in traditional distribution channels and online.



Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, and continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws. This press release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements.  Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks various risk factors discussed in the Company’s Management’s Discussion and Analysis under the Company’s profile on   

Copyright (c) 2021 TheNewswire - All rights reserved.

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.